# Xylitol Use for Decolonization of C. Difficile in Patients With IBD

> **NCT05852587** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 99 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Clostridioides Difficile Infection

## Interventions

- **DRUG:** Xylitol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05852587
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2032-01-01
- **Final completion:** 2033-01-01
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05852587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05852587, "Xylitol Use for Decolonization of C. Difficile in Patients With IBD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05852587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*